# FDA Inspection 1121919 - Legacy Emanuel Medical Center - March 10, 2020

Source: https://www.keypedia.com/records/fda_inspections/legacy-emanuel-medical-center/2d63e6e4-9f6f-4045-be1a-7015c74b21eb
Source feed: FDA_Inspections

> FDA Inspection 1121919 for Legacy Emanuel Medical Center on March 10, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121919
- Company Name: Legacy Emanuel Medical Center
- Inspection Date: 2020-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1226424 - 2023-12-28](https://www.keypedia.com/records/fda_inspections/legacy-emanuel-medical-center/fdbd8757-0885-453b-b06c-653a02d5fe0c)
- [FDA Inspection 1121919 - 2020-03-10](https://www.keypedia.com/records/fda_inspections/legacy-emanuel-medical-center/e4ab5da8-acce-43e8-8fec-9088d6480c97)
- [FDA Inspection 1053026 - 2018-05-04](https://www.keypedia.com/records/fda_inspections/legacy-emanuel-medical-center/4fe43f70-0397-4793-b338-c434605157b5)
- [FDA Inspection 945478 - 2015-10-09](https://www.keypedia.com/records/fda_inspections/legacy-emanuel-medical-center/d81155c7-4208-426c-a80c-753af1dcb763)
- [FDA Inspection 857141 - 2013-11-15](https://www.keypedia.com/records/fda_inspections/legacy-emanuel-medical-center/66b7e450-02b8-486b-8c7e-6d70bfd22f72)

Company: https://www.keypedia.com/companies/legacy-emanuel-medical-center/6387e4b6-2419-412e-a968-60077926cf32

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d